National Peroxide board meet Aug 12, 2026: results

What the company has announced

National Peroxide Limited has scheduled a Board meeting for August 12, 2026. The meeting is expected to address both a revision to the company’s audited numbers for FY26 and the approval of the latest quarterly results. The disclosure matters for investors because it resets the timeline for when the market gets clarity on the June 2026 quarter performance. It also indicates that the company intends to place revised audited information for FY26 in the public domain. Separately, the company has already communicated that an earlier board meeting was deferred.

Agenda for the August 12, 2026 Board meeting

As per the stated agenda, the Board will consider and approve three key items. First, revised audited financial results for the quarter and financial year ended March 31, 2026. Second, revised audited financial statements for the financial year ended March 31, 2026. Third, unaudited financial results for the quarter ended June 30, 2026. Together, these items imply that investors will be looking for both updated audited FY26 disclosures and the company’s Q1 numbers. The company has not provided the result publication time in the information shared here.

The deferred August 3 meeting and why it matters

National Peroxide Limited had earlier planned a Board meeting on August 03, 2026 to consider and approve the unaudited financial results for the quarter ended June 30, 2026. The company informed the Bombay Stock Exchange on August 02, 2026 that this meeting was postponed due to unavoidable circumstances. With the deferral, investors waiting for Q1FY26 performance indicators were told to await a revised date. The company also stated that it would communicate the new schedule to the exchange in due course, in line with regulatory requirements. In the interim, the market had to work with existing disclosures and the last set of audited results already issued.

Trading window status

The company also indicated that the trading window for designated persons remains closed. It is set to stay shut until 48 hours after the results are declared. This is a standard compliance measure around unpublished price sensitive information. For market participants, the point to track is the eventual result declaration date, because that will determine when the trading window reopens. The company has linked the reopening timeline directly to the announcement of financial results.

What is known about the meeting timeline

Some of the information shared around the event sequence also provided a simple status snapshot. The original meeting date was stated as August 03, 2026, with the current status marked as Deferred. The revised date was listed as To be intimated in that timeline format. At the same time, the Board meeting is also described as being scheduled for August 12, 2026 with an expanded agenda that includes revised audited items and unaudited quarterly results. Investors typically track such updates closely because they affect the flow of audited and quarterly reporting into the public domain.

FY26 audited performance already disclosed earlier

Separately from the August meeting notices, the company has disclosed its audited performance for the quarter and year ended March 31, 2026, which was approved by the Board on April 30, 2026 after review by the audit committee on April 29, 2026. Key numbers reported include revenue from operations of ₹28,971.14 lakh (₹289.71 crore) for FY26 (standalone) and profit after tax (PAT) of ₹1,103.71 lakh (₹11.04 crore) for FY26 (standalone). The company also disclosed total income of ₹295.68 crore and PAT of ₹11.04 crore for FY2026, alongside a comparison point that FY2025 had a loss of ₹2.25 crore.

Q4 FY26 numbers and the dividend decision

For Q4 FY26 (standalone), the company reported profit after tax of ₹792.86 lakh (₹7.93 crore). The Board also recommended a final dividend of ₹7 per equity share for FY26, described as a 70% dividend, and clarified it is subject to shareholder approval at the upcoming AGM. In addition, the company disclosed a commission of ₹0.17 crore to non-executive directors, which is also subject to shareholder approval. The statutory auditors issued an unmodified report, confirming the audited set was approved without qualification.

Key facts at a glance

Governance updates also disclosed

Alongside the audited result announcement cycle, the company also disclosed that Mr. Akshay Satasiya was appointed as Company Secretary and Compliance Officer, and as a Key Managerial Personnel, with effect from March 9, 2026. While this is separate from quarterly performance, such disclosures are tracked because compliance and governance roles are central to timely reporting. The company’s board-level approvals and exchange intimations around results, dividends, and KMP appointments collectively form the compliance trail investors rely on.

What investors will watch next

The next key milestone is the Board’s consideration of the unaudited financial results for the quarter ended June 30, 2026, and the revised audited FY26 numbers and statements. Investors will also watch for the company’s communication to the exchange after the meeting concludes, including any updated schedules if timelines change again. The dividend recommendation already made for FY26 remains subject to shareholder approval at the AGM, which is another upcoming event on the corporate calendar. Until the results are declared, the company has indicated the trading window remains closed for designated persons.